XSHG
600165
Market cap796mUSD
Oct 09, Last price
3.38CNY
1D
2.42%
1Q
24.72%
Jan 2017
-72.30%
Name
Ningxia Xinri Hengli Steel Wire Co Ltd
Chart & performance
P/E
—
P/S
12.29
EPS
—
Div yield, %
—
Shrs. gr., 5y
19.07%
Rev. gr., 5y
30.13%
Revenues
444m
+28.72%
Net income
-90m
L-83.23%
CFO
-373m
L+338.31%
Dividend
Jun 18, 20010.685 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ningxia Zhongke Biotechnology Co., Ltd., established in 1958 and headquartered in Yinchuan, China, operates in the chemical sector. The company specializes in the production of both chemical raw materials and a diverse range of chemical products. Its manufacturing activities specifically encompass coal-based activated carbon, various lauric acid compounds, and biologically-derived chemical fibers.
Key people
Rui Chen
Chief Financial Officer, General Manager, Director · since 2019
Jinwei Han
Deputy General Manager · since 2019
Haixi Xu
Deputy General Manager · since 2001
Qingxue Jing
Chief Engineer · since 2001
Xiaoping Gao
Chairman of the Board · since 2019
Jianming Yu
Chairman of the Board · since 2015
Independent Director · since 2010
Independent Director · since 2010
Shouhao Xu
Independent Director · since 2011
Lingxiao Zhan
Independent Director · since 2011
Headquarters & legal address
宁夏回族自治区石嘴山市惠农区河滨工业园区03号
石嘴山市, NX 753200
CN
石嘴山市, NX 753200
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||